* "pen 1" development project with teva pharmaceutical relates to a generic form of forteo marketed by eli lilly 登録するここ. * Believes that teva may be "first applicant" to file an anda for a generic ...

BEECH ISLAND, S.C.--(BUSINESS WIRE)--Ambio, Inc., an innovative biotech company developing novel peptide drugs, biosimilar, bioequivalent, and other complex generic drugs, announced today that a ...